durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['nsclc', 'lung', 'in-person', 'aegean', 'sclc']
join us thursday (april 27, 6pm) in dc for an in-person on lung cancer to discuss the latest updates (including aegean for resectable nsclc from #aacr23) as well as #sclc, #kras, #egfr and more. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown, Co-Host Official @IASLC Podcast #ITYSL #HereWeGo